Miserez A R, Keller U
Department of Research, University Hospital, Basel, Switzerland.
Arterioscler Thromb Vasc Biol. 1995 Oct;15(10):1719-29. doi: 10.1161/01.atv.15.10.1719.
Familial defective apolipoprotein B-100 (FDB) is a recently identified autosomal-dominantly inherited disorder caused by a point mutation in the apolipoprotein (apo) B gene. To determine whether the phenotypic characteristics in FDB subjects are similar to those in subjects with familial hypercholesterolemia (FH), 76 kindreds fulfilling the clinical criteria for heterozygous FH/FDB were characterized using molecular biological techniques. Allele-specific polymerase chain reaction (PCR) at the apoB locus was used for diagnosis or exclusion of FDB. PCR-based methods for detection of two point mutations (V408M and P664L) at the LDL receptor (LDLR) locus, cosegregation analysis using eight restriction fragment length polymorphisms (RFLPs) at the LDLR locus, or the exclusion of FDB confirmed the clinical diagnosis of FH. Three kindreds were not included because of a missing cosegregation between a particular haplotype and the FH phenotype. We predicted that a similar number of kindreds would be detected in the two groups, assuming comparable prevalences of the diseases in our population and similar phenotypic characteristics. However, only nine kindreds were identified with the FDB mutation compared with 64 kindreds with FH (P < .0001). From these 73 kindreds, 28 FDB heterozygotes and 129 FH heterozygotes were compared using multivariate analysis. There were no differences between these two groups with respect to age, sex, and apoE genotype distribution, lipoprotein(a) concentrations, body mass index, blood pressure, and smoking habits. However, FDB subjects demonstrated significantly lower concentrations of total cholesterol (8.1 versus 10.2 mmol/L, P < .001), LDL cholesterol (6.3 versus 8.2 mmol/L, P < .001), and triglycerides (1.3 versus 1.8 mmol/L, P = .025) and higher concentrations of HDL cholesterol (1.4 versus 1.2 mmol/L, P = .015) than subjects with FH. In contrast to FH, female FDB subjects tended to have higher concentrations of total cholesterol (8.9 versus 7.5 mmol/L, P = .032) and LDL cholesterol (7.1 versus 5.7 mmol/L, P = .026) than FDB males. The same results regarding total and LDL cholesterol and sex differences were observed when individual data of 238 FDB and 415 FH subjects from the literature were compared. In addition, FDB subjects showed much larger total cholesterol fluctuations than FH subjects (median of intraindividual coefficients of variation: FDB, 14.5%; FH, 5.3%; P < .001). In summary, these results demonstrate that FDB subjects tend to have a milder form of hyperlipoproteinemia than FH subjects and that only a part of the subjects with FDB fulfill the established criteria for identifying FH.
家族性载脂蛋白B-100缺陷症(FDB)是一种最近发现的常染色体显性遗传疾病,由载脂蛋白(apo)B基因中的点突变引起。为了确定FDB患者的表型特征是否与家族性高胆固醇血症(FH)患者相似,我们使用分子生物学技术对76个符合杂合子FH/FDB临床标准的家族进行了特征分析。采用载脂蛋白B基因座的等位基因特异性聚合酶链反应(PCR)来诊断或排除FDB。利用基于PCR的方法检测低密度脂蛋白受体(LDLR)基因座的两个点突变(V408M和P664L),使用LDLR基因座的8个限制性片段长度多态性(RFLP)进行共分离分析,或排除FDB来确诊FH的临床诊断。由于特定单倍型与FH表型之间缺乏共分离,三个家族未被纳入。假设我们人群中这两种疾病的患病率相当且表型特征相似,我们预计在两组中检测到的家族数量相近。然而,与64个FH家族相比,仅鉴定出9个携带FDB突变的家族(P <.0001)。从这73个家族中,使用多变量分析对28名FDB杂合子和129名FH杂合子进行了比较。在年龄、性别、载脂蛋白E基因型分布、脂蛋白(a)浓度、体重指数、血压和吸烟习惯方面,这两组之间没有差异。然而,FDB患者的总胆固醇(8.1对10.2 mmol/L,P <.001)、低密度脂蛋白胆固醇(6.3对8.2 mmol/L,P <.001)和甘油三酯(1.3对1.8 mmol/L,P =.025)浓度显著低于FH患者,而高密度脂蛋白胆固醇(1.4对1.2 mmol/L,P =.015)浓度则高于FH患者。与FH不同的是,FDB女性患者的总胆固醇(8.9对7.5 mmol/L,P =.032)和低密度脂蛋白胆固醇(7.1对5.7 mmol/L,P =.026)浓度往往高于FDB男性患者。当比较来自文献的238名FDB和415名FH患者的个体数据时,观察到了关于总胆固醇和低密度脂蛋白胆固醇以及性别差异的相同结果。此外,FDB患者的总胆固醇波动比FH患者大得多(个体内变异系数中位数:FDB为14.5%;FH为5.3%;P <.001)。总之,这些结果表明,FDB患者的高脂血症形式往往比FH患者轻,并且只有一部分FDB患者符合既定的FH诊断标准。